Assessment of Malaria In Vitro Drug Combination Screening and Mixed-Strain Infections Using the Malaria Sybr Green I-Based Fluorescence Assay
- 1 June 2009
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 53 (6), 2557-2563
- https://doi.org/10.1128/aac.01370-08
Abstract
Several drug development strategies, including optimization of new antimalarial drug combinations, have been used to counter malaria drug resistance. We evaluated the malaria Sybr green I-based fluorescence (MSF) assay for its use in in vitro drug combination sensitivity assays. Drug combinations of previously published synergistic (atovaquone and proguanil), indifferent (chloroquine and azithromycin), and antagonistic (chloroquine and atovaquone) antimalarial drug interactions were tested against Plasmodium falciparum strains D6 and W2 using the MSF assay. Fifty percent inhibitory concentrations (IC 50 s) were calculated for individual drugs and in fixed ratio combinations relative to their individual IC 50 s. Subsequent isobologram analysis and fractional inhibitory concentration determinations demonstrated the expected drug interaction pattern for each combination tested. Furthermore, we explored the ability of the MSF assay to examine mixed parasite population dynamics, which are commonly seen in malaria patient isolates. Specifically, the capacity of the MSF assay to discern between single and mixed parasite populations was determined. To simulate mixed infections in vitro, fixed ratios of D6 and W2 strains were cocultured with antimalarial drugs and IC 50 s were determined using the MSF assay. Dichotomous concentration curves indicated that the sensitive and resistant parasites composing the genetically heterogeneous population were detectable. Biphasic analysis was performed to obtain subpopulation IC 50 s for comparison to those obtained for the individual malaria strains alone. In conclusion, the MSF assay allows for reliable antimalarial drug combination screening and provides an important method to discern between homogenous and heterogeneous parasite populations.Keywords
This publication has 40 references indexed in Scilit:
- In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screenProceedings of the National Academy of Sciences of the United States of America, 2008
- Declining Artesunate-Mefloquine Efficacy against Falciparum Malaria on the Cambodia–Thailand BorderEmerging Infectious Diseases, 2008
- In vitro evaluations of antimalarial drugs and their relevance to clinical outcomesInternational Journal for Parasitology, 2008
- Assessment and Continued Validation of the Malaria SYBR Green I-Based Fluorescence Assay for Use in Malaria Drug ScreeningAntimicrobial Agents and Chemotherapy, 2007
- Comparison of a SYBR Green I-Based Assay with a Histidine-Rich Protein II Enzyme-Linked Immunosorbent Assay for In Vitro Antimalarial Drug Efficacy Testing and Application to Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2007
- High-Throughput Plasmodium falciparum Growth Assay for Malaria Drug DiscoveryAntimicrobial Agents and Chemotherapy, 2007
- Searching for New Antimalarial Therapeutics amongst Known DrugsChemical Biology & Drug Design, 2006
- Drug Susceptibility and Genetic Evaluation of Plasmodium falciparum Isolates Obtained in Four Distinct Geographical Regions of KenyaAntimicrobial Agents and Chemotherapy, 2004
- Modelling a Predictable Disaster:: The Rise and Spread of Drug-resistant MalariaParasitology Today, 2000
- Malaria diagnosis by the polymerase chain reaction: a field study in southeastern VenezuelaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1998